Cargando…

Development of Parents’ of Children with Hymenoptera Venom Allergy Quality of Life Scale (PoCHVAQoLS)

INTRODUCTION: Venom allergy in children, as a potentially life-threatening disease, may have a considerable impact on the quality of life of the parents of the affected patients. AIM: To present development of the quality of life scale for such parents. MATERIAL AND METHODS: The study sample include...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brzyski, Piotr, Cichocka-Jarosz, Ewa, Lis, Grzegorz, Tobiasz-Adamczyk, Beata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495112/ https://www.ncbi.nlm.nih.gov/pubmed/26161053 http://dx.doi.org/10.5114/pdia.2015.48042

Ejemplares similares

Development of children’s hymenoptera venom allergy quality of life scale (CHVAQoLS)
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2013)

Stinging insect identification in children with Hymenoptera venom allergy and their parents
por: Kaszuba, Jagoda, et al.
Publicado: (2023)

Congruence of the current practices in Hymenoptera venom allergic patients in Poland with EAACI guidelines
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2011)

Health-related quality of life in Polish adolescents with Hymenoptera venom allergy treated with venom immunotherapy
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2012)

Current practices in diagnosis of Hymenoptera venom allergy in Poland
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2021)

Venom allergy treatment practices in Poland in comparison to guidelines: next edition of the national audit
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2019)

Skin prick tests are not useful for the qualification for venom immunotherapy in children
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2023)

Is the clinical manifestation of anaphylaxis in children influenced by the trigger of reaction?
por: Tarczoñ, Izabela, et al.
Publicado: (2020)

Intervention in anaphylaxis: the experience of one paediatric centre based on NORA reports
por: Tarczoń, Izabela, et al.
Publicado: (2020)

Risk factors in Hymenoptera venom allergy
por: Ruëff, F., et al.
Publicado: (2017)

Component resolved diagnostics for hymenoptera venom allergy
por: Jakob, Thilo, et al.
Publicado: (2017)

Proteomic features characterization of Hymenoptera venom allergy
por: Matuszewska, Eliza, et al.
Publicado: (2019)

Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy
por: Paolocci, Giulia, et al.
Publicado: (2014)

Types of laryngomalacia in children: interrelationship between clinical course and comorbid conditions
por: Kusak, Beata, et al.
Publicado: (2016)

Benefits and limitations of sting challenge in hymenoptera venom allergy
por: Aßmus, Katharina, et al.
Publicado: (2021)

Antigen 5 Allergens of Hymenoptera Venoms and Their Role in Diagnosis and Therapy of Venom Allergy
por: Blank, Simon, et al.
Publicado: (2020)

9α,11β-PGF(2), a Prostaglandin D(2) Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients
por: Nittner-Marszalska, Marita, et al.
Publicado: (2015)

Gene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy
por: Niedoszytko, Marek, et al.
Publicado: (2013)

Facing Hymenoptera Venom Allergy: From Natural to Recombinant Allergens
por: Perez-Riverol, Amilcar, et al.
Publicado: (2015)

Diagnosis of Hymenoptera Venom Allergy: State of the Art, Challenges, and Perspectives
por: Matysiak, Joanna, et al.
Publicado: (2022)

90 Improving the Diagnosis of Hymenoptera Venom Allergy: Component Resolved Diagnosis
por: Cifuentes, Liliana, et al.
Publicado: (2012)

New Biomarkers of Hymenoptera Venom Allergy in a Group of Inflammation Factors
por: Packi, Kacper, et al.
Publicado: (2021)

Platelet‐activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy?
por: Bilò, Maria Beatrice, et al.
Publicado: (2021)

Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics
por: Jakob, Thilo, et al.
Publicado: (2017)

Add-on treatment with nebulized hypertonic saline in a child with plastic bronchitis after the Glenn procedure,
por: Lis, Grzegorz, et al.
Publicado: (2014)

PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
por: Yavuz, Suleyman Tolga, et al.
Publicado: (2014)

Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
por: Sahiner, Umit Murat, et al.
Publicado: (2019)

Allergen-specific immunotherapy of Hymenoptera venom allergy – also a matter of diagnosis
por: Schiener, Maximilian, et al.
Publicado: (2017)

Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy
por: Jovanovic, Dragana, et al.
Publicado: (2023)

Hymenoptera Allergens: From Venom to “Venome”
por: Spillner, Edzard, et al.
Publicado: (2014)

Allergy and sensitization to Hymenoptera venoms in unreferred adults with a high risk of sting exposure
por: Zink, Alexander, et al.
Publicado: (2019)

Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes
por: Blank, Simon, et al.
Publicado: (2020)

Impact of specific immunotherapy and sting challenge on the quality of life in patients with hymenoptera venom allergy
por: Eitel, Tamara, et al.
Publicado: (2021)

Analysis of Hymenoptera venom allergy in own material. Clinical evaluation of reactions following stings, in patients qualified for venom immunotherapy
por: Chciałowski, Andrzej, et al.
Publicado: (2018)

The Honeybee Venom Major Allergen Api m 10 (Icarapin) and Its Role in Diagnostics and Treatment of Hymenoptera Venom Allergy
por: Jakob, Thilo, et al.
Publicado: (2020)

Allergen immunotherapy for insect venom allergy: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy
por: Sills, Eric Scott, et al.
Publicado: (2004)

Clinical Features and the Diagnostic Value of Component Allergen-Specific IgE in Hymenoptera Venom Allergy
por: Shin, Yoo Seob, et al.
Publicado: (2012)

Hymenoptera venom allergy in outdoor workers: Occupational exposure, clinical features and effects of allergen immunotherapy
por: Toletone, Alessandra, et al.
Publicado: (2016)

Single‐cell profiling reveals novel cellular heterogeneity of monocytes during Hymenoptera venom allergy
por: Chao, Wen‐Cheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7030tcd0gf1vdgamrgh3rsq606